GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envista Holdings Corp (NYSE:NVST) » Definitions » EPS (Diluted)

Envista Holdings (Envista Holdings) EPS (Diluted) : $-0.61 (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Envista Holdings EPS (Diluted)?

Envista Holdings's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $-1.27. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.61.

Envista Holdings's EPS (Basic) for the three months ended in Dec. 2023 was $-1.27. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.55.

Envista Holdings's EPS without NRI for the three months ended in Dec. 2023 was $0.29. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $0.95.

During the past 12 months, Envista Holdings's average EPS without NRIGrowth Rate was 14.20% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 80.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 5.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Envista Holdings's highest 3-Year average EPS without NRI Growth Rate was 80.50% per year. The lowest was -48.90% per year. And the median was -0.30% per year.


Envista Holdings EPS (Diluted) Historical Data

The historical data trend for Envista Holdings's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envista Holdings EPS (Diluted) Chart

Envista Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial 1.60 0.20 1.92 1.37 -0.60

Envista Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 0.25 0.29 0.12 -1.27

Competitive Comparison of Envista Holdings's EPS (Diluted)

For the Medical Instruments & Supplies subindustry, Envista Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Envista Holdings's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Envista Holdings's PE Ratio distribution charts can be found below:

* The bar in red indicates where Envista Holdings's PE Ratio falls into.



Envista Holdings EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Envista Holdings's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-100.2-0)/166.900
=-0.60

Envista Holdings's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-217.4-0)/171.700
=-1.27

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Envista Holdings  (NYSE:NVST) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Envista Holdings EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Envista Holdings's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Envista Holdings (Envista Holdings) Business Description

Traded in Other Exchanges
Address
200 S. Kraemer Boulevard, Building E, Brea, CA, USA, 92821
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.
Executives
Eric Conley officer: SVP, Orthodontics 200 S. KRAEMER BLVD, BLDG E, BREA CA 92821
Mark E Nance officer: Senior Vice President, GC, Sec 1333 S SPECTRUM BLVD #100, CHANDLER AZ 85286
Stephen Keller officer: Principal Financial Officer 200 S. KRAEMER BLVD., BUILDING E, BREA CA 92821
Amir Aghdaei director, officer: PRESIDENT AND CEO C/O CREDENCE SYSTEMS CORPORATION, 1421 CALIFORNIA CIRCLE, MILPITAS CA 95035
Faez C Kaabi officer: Chief Accounting Officer 200 S. KRAEMER BLVD., BUILDING E, BREA CA 92821
Howard H Yu officer: SENIOR VICE PRESIDENT, CFO 250 S. KRAEMER BLVD., BREA CA 92821
Mischa Reis officer: SENIOR VICE PRESIDENT C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD, BLDG. E, BREA CA 92821
Curt W Bludworth officer: SENIOR VICE PRESIDENT, CHRO 250 S. KRAEMER BLVD., BREA CA 92821
Barbara B. Hulit director C/O FORTIVE CORPORATION, 6920 SEAWAY BLVD, EVERETT WA 98203
Jeffrey Kappler officer: SENIOR VICE PRESIDENT C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD, BLDG. E, BREA CA 92821
Teresa Gayle Sheppard director C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD., BLDG. E, BREA CA 92821
Vivek Jain director ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Jean-claude Kyrillos officer: Senior Vice President C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD., BLDG. E, BREA CA 92821
Kieran Gallahue director PO BOX 684369, PARK CITY UT 84068
William K Daniel director 2135 WEST MAPLE ROAD, TROY MI 48084